Pancreatic Cancer’s Two-Faced Driver: HNF4G vs FOXA1
Groundbreaking research uncovers how pancreatic cancer switches between two transcription factors for different stages of disease progression. The discovery reveals new therapeutic vulnerabilities in one of oncology’s most challenging cancers.